Crescita Therapeutics (TSE:CTX) Stock Price Down 7.4% – Here’s What Happened

Crescita Therapeutics Inc. (TSE:CTX) traded down 7.4% during trading on Tuesday . The stock traded as low as C$0.43 and last traded at C$0.44. 57,401 shares changed hands during trading, an increase of 197% from the average session volume of 19,351 shares. The stock had previously closed at C$0.47.

Crescita Therapeutics Stock Down 13.0%

The company has a debt-to-equity ratio of 5.77, a current ratio of 2.70 and a quick ratio of 2.29. The firm has a 50-day moving average of C$0.46 and a 200 day moving average of C$0.48. The stock has a market capitalization of C$7.45 million, a price-to-earnings ratio of 20.00 and a beta of -0.02.

Crescita Therapeutics (TSE:CTX) last announced its quarterly earnings data on Wednesday, November 5th. The company reported C$0.04 earnings per share (EPS) for the quarter. Crescita Therapeutics had a negative return on equity of 15.60% and a negative net margin of 15.73%.The company had revenue of C$5.39 million for the quarter.

Crescita Therapeutics Company Profile

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin.